Related Experiment Video
Updated: Aug 17, 2026

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles
Published on: January 4, 2012
Galanin and galanin receptors in human cancers
Alexandra Berger1, Radmila Santic, Cornelia Hauser-Kronberger
1Department of Pediatrics, Paracelsus Private Medical University, Salzburg, Muellner-Hauptstrasse 48, A-5020 Salzburg, Austria.
Abstract:
The increasing interest in peptides and peptide receptors in cancer is based on the possibility of receptor targeting, because peptide receptors are often expressed in different human tumors. The neuropeptide galanin has also been suggested to be involved in the development of neuroendocrine tumors based on the development of estrogen-induced tumors in estrogen-sensitive rats. This study summarizes our current knowledge on the expression of galanin peptide and galanin receptors in different human neuroendocrine tumors. The expression of both, peptide and corresponding receptor, seems to be a common feature of human gliomas, pheochromocytomas, pituitary and neuroblastic tumors. The co-expression of galanin and its receptors supports a role for galanin in tumor cell pathology via autocrine/paracrine mechanisms.
Insights
Galanin peptide and its receptors are commonly found in human neuroendocrine tumors like gliomas and pheochromocytomas. This co-expression suggests galanin plays a role in tumor cell growth through autocrine/paracrine signaling.
Area of Science:
- Oncology
- Neuroendocrinology
- Molecular Biology
Background:
- Peptide receptors are frequently expressed in human tumors, offering potential for targeted therapies.
- Galanin, a neuropeptide, is implicated in neuroendocrine tumor development, supported by studies in estrogen-sensitive rats.
Purpose of the Study:
- To review the expression of galanin peptide and its receptors in various human neuroendocrine tumors.
- To evaluate the potential role of galanin signaling in neuroendocrine tumor pathology.
Main Methods:
- Literature review of studies investigating galanin and galanin receptor expression.
- Analysis of expression patterns in human gliomas, pheochromocytomas, pituitary tumors, and neuroblastic tumors.
Main Results:
- Galanin peptide and its corresponding receptors are commonly expressed in human gliomas, pheochromocytomas, pituitary tumors, and neuroblastic tumors.
- Co-expression of galanin and its receptors is a frequent observation across these tumor types.
Conclusions:
- The co-expression of galanin and its receptors in neuroendocrine tumors supports a significant role for galanin in tumor cell pathology.
- Autocrine and/or paracrine mechanisms involving galanin signaling are likely involved in the progression of these tumors.
Related Concept Videos
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Non-Canonical Wnt Signaling Pathways
